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Summary
 
Different strains of mice have varying susceptibilities to ultraviolet radiation (UV) of wave-
length 280–320 nm (UVB) for 50% suppression of systemic contact hypersensitivity (CHS) re-
sponses. Prevalence of histamine-staining dermal mast cells in different strains of mice (C57BL/
6J, DBA/2, BALB/c) correlated directly with their susceptibility to UVB-induced systemic im-
munosuppression. BALB/c mice carrying 
 
Uvs1
 
, a major locus for susceptibility to UV-induced im-
munosuppression, contained greater numbers of dermal mast cells than BALB/c mice of the
same parental origin. Strains of mice that were differentiated on their susceptibility to UVB-
induced downregulation of systemic CHS responses were similar in their susceptibility to hista-
mine-induced immunomodulation. Histamine, but not UVB irradiation, decreased systemic
CHS responses in mast cell–depleted mice (
 
W
 
f
 
/W
 
f
 
). Reconstitution of the dorsal skin of 
 
W
 
f
 
/W
 
f
 
mice with bone marrow–derived mast cell precursors from nonmutant mice rendered the mice
susceptible to UVB irradiation for systemic suppression of CHS responses. UVB irradiation did
not suppress delayed type hypersensitivity responses to allogeneic spleen cells in 
 
W
 
f
 
/W
 
f
 
 mice. In
contrast, UV irradiation suppressed CHS responses in 
 
W
 
f
 
/W
 
f
 
 mice when hapten was applied
to the irradiated site. This study demonstrates that dermal mast cells are necessary for the induc-
tion of systemic suppression of CHS responses by UVB radiation, and suggests that mast cell–
derived histamine is one component of this UVB-induced systemic immunosuppression.
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T
 
he acute effects of UV irradiation of skin may include
edema and erythema. However, UV irradiation also
suppresses the immune system and provides a mechanism
by which UV-induced tumors escape immune destruction
(1). UV-induced immunosuppression has been investigated
for potential use in a transplantation setting (2) and in treat-
ment of inflammatory diseases of the skin (3). However,
mice of different strains differ in their susceptibility to UV
radiation of wavelength 280–320 nm (UVB)
 
1
 
-induced im-
munosuppression (4, 5) and there is evidence that humans
with increased incidence of nonmelanoma skin tumors
have decreased contact hypersensitivity (CHS) responses to
haptens after UVB exposure (6). The mechanisms by
which UV irradiation, in particular UVB of 280–320 nm,
can regulate immune responses have been the focus of
many studies.
Recognizing C57BL/6 and BALB/c mice as relatively
susceptible and resistant, respectively, to UVB-induced im-
munosuppression, a genetic basis for these differences in
susceptibility of different mouse strains to UVB has been
sought. In a comprehensive study of 18 strains of inbred
mice, three phenotypes with significantly different suscep-
tibilities to UV suppression were identified, namely high
susceptibility with 50% suppression at 0.7–2.3 kJ/m
 
2
 
 UVB,
intermediate susceptibility with 50% suppression at 4.7–6.9
kJ/m
 
2
 
 UVB, and low susceptibility (but not resistance)
with 50% suppression at 9.6–12.3 kJ/m
 
2
 
 UVB. Representa-
tive strains of mice from these three groups were C57BL/6,
DBA/2, and BALB/c, respectively (5). In these studies of
UV-induced “systemic” immunosuppression in which the
sensitizing hapten was applied to unirradiated sites 3–5 d af-
 
1
 
Abbreviations used in this paper:
 
 CHS, contact hypersensitivity; DTH, de-
layed type hypersensitivity; SCFT, subcutaneous fatty tissue; TNCB,
2,4,6-trinitrochlorobenzene; UCA, urocanic acid; UVB, UV radiation of
wavelength 280–320 nm.
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ter irradiation, MHC haplotype did not correlate with UV
suppression in four MHC congenic strains (5). In contrast,
polymorphisms at a locus within the murine MHC and at
the 
 
Lps
 
 locus, in turn controlling transcription and transla-
tion of the 
 
Tnf-
 
a
 
 gene, were shown to correlate with sus-
ceptibility to the effects of UVB for “local” suppression,
i.e., of CHS responses to haptens or antigens applied to
UV-irradiated sites (4, 7).
Further studies in mice of UVB-induced systemic im-
munosuppression have identified the locus, 
 
Uvs1
 
, as a ma-
jor locus for susceptibility to UV suppression (8). BALB/c-
 
Uvs1
 
 mice were derived by nine generations of successive
backcrossing of F
 
1
 
 hybrid BALB/c 
 
3 
 
C57BL/6 (CB6F
 
1
 
)
mice to the BALB/c parent with selection for high suscep-
tibility to UV suppression (8), followed by three genera-
tions of intercrossing. Under these conditions, high suscep-
tibility segregates as an autosomal dominant trait. Both
BALB/c and BALB/c-
 
Uvs1
 
 mice are albino. With a dose
of UV of 4.5 kJ/m
 
2
 
, C57BL/6 mice (
 
n
 
 5 
 
39) show a mean
percent suppression of 84 
 
6
 
 3, BALB/c mice (
 
n
 
 5 
 
55) of
30 
 
6
 
 3 and BALB/c-
 
Uvs1
 
 (
 
n
 
 5 
 
123) of 53 
 
6
 
 2 (8).
Dermal mast cells are activated and degranulate after
UVB irradiation (9). Findings of reduced UV-induced
swelling in the ears of mast cell–deficient mice (
 
W/Wv
 
;
reference 10) support the conclusion that mast cells play an
important role in UV-induced inflammation. Histamine is
the major biogenic amine of skin mast cells and is stored
bound to proteoglycans in cytoplasmic granules (11). As
histamine provides an important signal to keratinocytes to
produce prostanoids (12, 13), and in vivo
 
 
 
studies by us and
others with histamine receptor antagonists (14, 15) and in-
domethacin (13, 16) have highlighted directly or indirectly
histamine and prostanoid involvement in UVB-induced
immunosuppression, we investigated the distribution of
histamine-staining mast cells by immunohistochemistry in
the dermis and subcutaneous fatty tissue (SCFT, also
known as the hypodermis, the hypodermal fat layer or the
stratum adiposum) of C57BL/6J, DBA/2, BALB/c, and
BALB/c-
 
Uvs1
 
 female mice and the correlation of these
with their susceptibility to UVB-induced systemic suppres-
sion of CHS responses. Further, we investigated the sus-
ceptibility of mast cell–depleted mice to the immunomod-
ulatory effects of both UV irradiation and administration of
histamine. In these latter studies, the involvement of mast
cells in the ability of UVB radiation to modulate local as
well as systemic CHS responses was investigated, and also
in a delayed type hypersensitivity (DTH) response to allo-
geneic spleen cells. The effect of reconstitution of the dor-
sal skin of mast cell–depleted mice with dermal mast cells
on susceptibility to systemic immunomodulation by UVB
was also examined.
 
Materials and Methods
 
Mice.
 
Pathogen-free, female BALB/c, DBA/2, and C57BL/6J
mice were obtained (Animal Resource Center of the South Aus-
tralian Department of Agriculture, Adelaide, Australia). Mice car-
rying the 
 
W
 
f
 
 mutation on both the C57BL/6 and DBA/2 back-
ground were obtained originally from the Walter and Eliza Hall
Institute of Medical Research (Melbourne, Australia; reference
17). The homozygous mast cell–depleted mice (
 
W
 
f
 
/
 
W
 
f
 
), the
heterozygous mice (
 
W
 
f
 
/
 
1
 
), and the wild-type mice (
 
1
 
/
 
1
 
) were
the progeny of the mating of (C57BL/6
 
W
 
f
 
 
 
3 
 
DBA/2
 
W
 
f
 
) F1
hybrids, with the 
 
W
 
f
 
/
 
W
 
f
 
, 
 
W
 
f
 
/
 
1
 
, and 
 
1
 
/
 
1
 
 mice identified by
coat color. The parental strains for the 
 
Uvs1
 
 mice were obtained
from the Frederick Cancer Research Facility (Frederick, MD).
All mice were of equivalent age (69–80 d) and were not in hair
growth as determined by histology and increased skin fold thick-
ness. All experiments were performed according to the ethical
guidelines of the National Health and Medical Research Council
of Australia.
 
Immunohistochemical Staining for, and Quantification of, Histamine-
containing Mast Cells.
 
Samples of dorsal skin (2–4/mouse) were
rolled, fixed in 10% buffered formalin, and paraffin embedded en-
suring vertical orientation of the roll, and 4-
 
m
 
m sections were cut
and immunohistochemically stained with a 1/400 dilution of rab-
bit polyclonal antihistamine antibody (Chemicon, Temecula,
CA). After incubation with a biotin-conjugated sheep anti–rabbit
immunoglobulin (Silenus, Hawthorn, Australia) and peroxidase-
conjugated streptavidin (Dako, Carpinteria, CA), the reaction
product was developed with 3,3
 
9
 
-diaminobenzidine tetrahydro-
chloride (Sigma Chemical Co., St. Louis, MO). Sections were
counterstained with hematoxylin solution. Control sections were
incubated with diluted rabbit serum (1/400) or no primary anti-
body. The staining for histamine was specific as preincubation of
the antibody with histamine significantly reduced the staining de-
tected.
A video image analysis system (Video Pro 32; Leading Edge Pty
Ltd., Adelaide, South Australia) was used to quantify histamine-
staining cells in 15 consecutive fixed fields in each roll of skin.
The epidermis was orientated horizontally and using a 
 
3
 
10 ob-
jective and a 
 
3
 
2.5 camera eyepiece; fields covering the epidermis
through to the SCFT were selected. Mast cells (i.e., histamine-
staining cells) and area of dermis and SCFT per fixed field of 800-
 
m
 
m
width were measured (but expressed per mm); the coefficient of
variation for measurement of mean dermal area for 15 fields was
 
,
 
14%. Dermal mast cell prevalence (see Figs. 1 
 
A
 
 and 4 
 
A
 
) was
determined by dividing the mast cell numbers per mm horizontal
field length (Figs. 1 
 
B
 
 and 4 
 
B
 
) by the dermal area for that field
(Figs. 1 
 
C
 
 and 4 
 
C
 
). In all experiments, the identity of the sec-
tions for examination by video image analysis was coded except
for the positive control that was a section from skin rolls prepared
from a C57BL/6J mouse. This positive control demonstrated
minimal difference in staining intensity for mast cells from differ-
ent staining runs. For measurement of the image background in
all measurements of optical density, readings were standardized
using a bright field image of the background illumination. This
allowed correction of nonuniform illumination over a field of
view, which would otherwise affect the discrimination of features
by their gray value.
For quantification of the histamine content in each cell, the in-
tegrated optical density (representing the total amount of hista-
mine staining in a given cell) was measured, as well as the area of
histamine staining in each cell. For two rolls from each of six
mice (three C57BL/6J and three BALB/c) all processed and
stained within the same staining run, 200 mast cells were captured
systematically in consecutive fields using a 
 
3
 
40 objective. The
cells were categorized according to distribution in the upper or
lower dermis (equal halves) or SCFT.
 
UV Irradiation.
 
The UV source was a bank of FS40 sunlamps 
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(Westinghouse Corp., Pittsburgh, PA) emitting a broad band of
UV, 250–360 nm, with 65% of the output in the UVB range
(280–320 nm). A polyvinylchloride plastic film was used to
screen out wavelengths of 
 
,
 
290 nm. The dose rate was moni-
tored using a UVX radiometer with a UVX-31 sensor (Ultravio-
let Products Inc., San Gabriel, CA). For irradiation of the mice, a
uniform dorsal area (8 cm
 
2
 
) was clean shaven, the ears protected
with black adhesive insulation tape, and the mice housed in indi-
vidual compartments of perspex cages. The sunlamps were held
20 cm above the cages.
 
Histamine Administration.
 
Histamine (0.2–200 
 
m
 
g/mouse; Sigma
Chemical Co.) was dissolved in mouse osmolality PBS (330
mOsm/kg H
 
2
 
O) and injected subcutaneously into the backs of
mice 5 d before sensitization with hapten. All mice received an
equal volume of diluent, with or without histamine.
 
Assay of CHS.
 
For assay of systemic CHS responses, 5 d after
UVB irradiation or histamine administration, mice (five per
group) were sensitized on the shaved ventral skin with 100 
 
m
 
l of
freshly prepared 5% (wt/vol) 2,4,6-trinitrochlorobenzene (TNCB;
Tokyo Kasei Kogyo Ltd., Tokyo, Japan) in acetone. 5 d later and
after coding the identities of the mouse groups, a CHS response
was elicited by applying 10 
 
m
 
l freshly prepared 1% TNCB in ace-
tone to each of the ventral and dorsal surfaces of both ears. 24 h
after challenge, the ear thickness was measured with a micrometer
(Mitutoyo Corp., Tokyo, Japan) and the extent of ear swelling
for each mouse was calculated by subtracting the ear thickness be-
fore challenge. The mean swelling measured in mice that were
challenged, but not sensitized, with TNCB (
 
z
 
0.03 mm) was sub-
tracted from this value. For local CHS responses, mice were sen-
sitized 3 d after irradiation on the same dorsal site as UVB-irradi-
ated with 100 
 
m
 
l freshly prepared 1% TNCB in acetone. The
challenge of ears with TNCB was as described above.
 
Assay of DTH.
 
4 d after UVB irradiation, 
 
W
 
f
 
/
 
W
 
f
 
 
 
and 
 
W
 
f
 
/
 
1
 
mice were immunized by subcutaneous injection of 2.5 
 
3 
 
10
 
7
 
allogeneic spleen cells (from BALB/c mice) in 50 
 
m
 
l PBS into
each flank of each mouse. 7 d later, the thickness of the hind
footpads of the animals was measured with a micrometer before
challenge with a subcutaneous injection of 10
 
7
 
 allogeneic spleen
cells in a volume of 40 
 
m
 
l PBS. After 24 h, the footpad thickness
was measured again and the extent of swelling for each footpad
was calculated by subtracting the footpad thickness before challenge.
 
Reconstitution of the Dorsal Skin of W
 
f
 
/W
 
f
 
 Mice with Bone Mar-
row–derived Mast Cell Precursors.
 
Bone marrow cells from wild-
type (
 
1
 
/
 
1
 
) mice were cultured at 10
 
6
 
/ml in Eagles’s MEM,
alpha modification (alpha MEM; Sigma Chemical Co.) supple-
mented with 10
 
2
 
4
 
 M 2-mercaptoethanol, 20% horse serum
(Gilles Plains Animal Resource Centre, Adelaide, Australia), and
10% pokeweed-mitogen–stimulated spleen cell–conditioned me-
dium (PWM-SCM). PWM-SCM was prepared as previously
published (18) with 2 
 
3 
 
10
 
6
 
 cells/ml incubated for 5 d in alpha
MEM supplemented with 10% fetal calf serum, 10
 
25 M 2-mer-
captoethanol, and 1:300 dilution of pokeweed mitogen (Sigma
Chemical Co.). Culture flasks were incubated at 378C in 5% CO2
with half the medium replaced every 7 d. After 31 d, the cells
were washed and suspended in alpha MEM (2.5 3 106/ml) for
injection in vivo. Each W f/W f mouse received 106 cells in 8 3 50
ml subcutaneous injections in two rows within a 1-cm width 3 2-cm
length of shaved dorsal skin. From 3.00 3 108 bone marrow cells
harvested from 16 1/1 mice, 2.3 3 107 cells (7.6% yield) were
harvested at the end of the 31-d culture period. The cultured
cells (.85%) stained blue after staining with alcian blue–safranin
(Csaba’s mast cell stain; reference 19) indicating immature mast
cells.
6 wk after reconstitution, an 8-cm2 dorsal area was shaved on
the 18 W f/W f mice injected with bone marrow–derived mast
cell precursors (10 male, 8 female). On the next day, 13 mice
were irradiated with 12 kJ/m2 UVB and 5 served as controls. 5 d
later, the mice were assessed for a systemic CHS response as de-
scribed above. At the end of the systemic CHS assay, the mice
were killed and dorsal skin sampled for evaluation of mast cell
numbers. Mast cells in the dorsal skin of the bone marrow–recon-
stituted W f/W f mice were confirmed to be mature connective
tissue mast cells by staining red with the alcian blue–safranin
staining procedure (data not shown).
Expression of Results and Statistical Analysis. For mast cell quan-
tification and measurement of area of the dermis and SCFT, a
mean value for each mouse was determined from 30–60 measure-
ments. For measurement of integrated optical density and stained
area per cell, the mean result from individual mice was used to
calculate the mean value 6 SD for three mice. A multiple com-
parison procedure using a one-way analysis of variance and
Fisher’s least significant difference test was used to determine the
statistical significance (P ,0.05) of differences between groups of
mice from different strains. This form of analysis was also used for
a test of significance between groups of mice within a CHS ex-
periment. If the results from only two strains were compared
(e.g., BALB/c versus BALB/c-Uvs1, C57BL/6J versus BALB/c
for measurements of integrated optical density), an unpaired Stu-
dent’s t test was used. Strain-dependent effects of UVB or hista-
mine on CHS to TNCB was examined by a multifactorial analysis
of variance (MANOVA). Probabilities of ,0.05 were considered
significant.
Results
Dermal Mast Cells. With the use of a video image anal-
ysis system, the prevalence of histamine-staining dermal
mast cells (mast cells per mm2) was found to be significantly
greater in C57BL/6J mice than in DBA/2 mice (P ,0.05),
which in turn had a significantly greater dermal mast cell
prevalence than measured in BALB/c mice (P ,0.05; Fig. 1
A). When mast cell numbers and tissue areas were consid-
ered separately in the different mouse strains, similar signif-
icant differences (P ,0.05) were detected in dermal mast
cell numbers per mm horizontal field length (Fig. 1 B). In
the SCFT, there was no significant difference in the num-
ber of mast cells per mm horizontal field length of DBA/2
and BALB/c mice (Fig. 1 B). However, there was a signifi-
cant decrease in mast cell prevalence in the SCFT of
C57BL/6J mice (P ,0.05; Fig. 1 B). The area of the der-
mis or SCFT per unit horizontal length of tissue for the
three strains of mice examined did not vary significantly
(Fig. 1 C). There was a linear relationship between the
prevalence of histamine-staining dermal mast cells and the
log of the dose of UVB demonstrated by others (5) to cause
50% suppression of CHS responses in the different mouse
strains (Fig. 1 D). Representative histologic sections from
BALB/c and C57BL/6J mice are shown in Fig. 2, A and B,
respectively.
Differences in the histamine content of mast cells from
C57BL/6J and BALB/c mice were investigated by mea-
surement of the integrated optical density for histamine
staining in 400 skin mast cells/mouse. The relative distribu-2048 Mast Cells and Susceptibility to UVB Immunosuppression
tion of the 400 mast cells assessed varied for the different
mouse strains (Fig. 3 A), as well as the tissue area required
to be scanned in order to measure 400 mast cells. The
mean area for histamine staining in mast cells from all mice
was similar, the variation in stained areas approximating a
normal distribution. The mean integrated optical density
for histamine staining per cell was very similar for C57BL/6J
and BALB/c mice (Fig. 3 B).
BALB/c-Uvs1 Mice. Mast cell numbers in the dermis
and SCFT of BALB/c-Uvs1 mice and BALB/c mice of the
same parental origin were investigated (Fig. 4). Within
each of the three experiments (five BALB/c-Uvs1 and five
BALB/c in experiment 1, three BALB/c-Uvs1 and two
BALB/c in experiment 2, and three BALB/c-Uvs1 and
two BALB/c in experiment 3), all BALB/c-Uvs1 animals
were littermates. Dermal mast cell numbers were signifi-
cantly higher in the BALB/c-Uvs1 mice (P 5 0.0001; Fig.
4 A), although there were no differences in the numbers of
mast cells in the SCFT (Fig. 4 B). It should be noted that
variation in dermal mast cell numbers within the BALB/c-
Uvs1 group occurred in all three experiments (three high
and two low in experiment 1, two high and one low in ex-
periment 2, and two high and one low in experiment 3).
Dermal areas for the BALB/c-Uvs1 and BALB/c mice
were not significantly different (Fig. 4 C).
Immunomodulation of Systemic CHS Responses. To confirm
that histamine was a mast cell product that could limit
quantitatively UVB-induced immunosuppression in BALB/c
(low susceptibility) versus C57BL/6J (high susceptibility)
mice, the different mouse strains were UVB irradiated or
injected subcutaneously with increasing doses of histamine
5 d before sensitization with the hapten, TNCB, and assay
of a CHS response to that hapten (Fig. 5). The strain-depen-
dent effects of UV on CHS to TNCB were significant by
multifactorial analysis of variance, with 50% suppression at
UVB doses as published (reference 5; Fig. 5 A). However,
there was no difference between the strains at a dose of
histamine that was immunosuppressive (20 mg/mouse; Fig.
5 B).
Mast Cell–depleted Mice. Mast cell–depleted mice (Wf/Wf;
reference 17) were then tested for susceptibility to UVB-
induced systemic immunosuppression. The prevalence of
dorsal dermal mast cells in the homozygous (W f/W f) mice
was z12% of that measured in wild-type mice of the same
Figure 1. Mast cells in the dorsal skin of C57BL/6J, DBA/2, and
BALB/c mice. (A) Mast cells per mm2 dermal area. (B) Mast cells per mm
horizontal field length in the dermis and SCFT of C57BL/6J (C57; n 5
10), DBA/2 (DBA; n 5 5), and BALB/c (B/c; n 5 11) mice. (C) The
area (mm2) of the dermis and SCFT per mm of fixed field length for the
same mice as shown in B. (D) The correlation between mast cell preva-
lence in the dermis (A) and susceptibility to UVB radiation for systemic
suppression of CHS responses. Each point in A and B represents the mean
mast cell number (expressed per area and fixed field length, respectively),
and in C, area per fixed field length for 30–60 measurements/mouse. In
A and D, the number of mice per group is shown in brackets. In D, the
mean mast cell number per mm2 dermis for 4-mm sections (6SD) was
plotted against the log of the UV dose (as documented by others [5]) re-
quired for 50% suppression of CHS responses.
Figure 2. Histologic sections of dorsal skin from representative mice. (A) BALB/c, (B) C57BL/6J. Arrows, Mast cells.2049 Hart et al.
genotype (Fig. 6 A). Systemic CHS responses by W f/W f
mice, in contrast to heterozygous (W f/1) and wild-type
(1/1) mice, were not suppressed by UVB at the dose of
irradiation tested (Fig. 6 B). However, when the mast cell
product histamine was exogenously introduced 5 d before
hapten sensitization, CHS responses in these animals were
reduced (Fig. 6 C).
In a manner similar to regulation of systemic CHS re-
sponses, UVB irradiation was able to suppress a DTH re-
sponse to allogeneic spleen cells in heterozygous (W f/1),
but not in homozygous (W f/W f), mice (representative of
two experiments in Table 1). In contrast, mast cell deple-
tion in mice did not affect downregulation of local CHS
responses by UVB irradiation, i.e., CHS responses after
sensitization with hapten applied to the irradiated site (rep-
resentative of two experiments in Table 1).
Figure 3. (A) Location of 400 mast cells from the dorsal skins of each
of three C57BL/6J and three BALB/c mice examined for histamine con-
tent. The proportion of mast cells (mean 1 SD) in the upper dermis (D),
lower dermis, and SCFT is shown. (B) Histamine content of these cells as
assessed by measuring the integrated optical density (mean 1 SD) for in-
dividual histamine-stained cells.
Figure 4. Mast cells in the
dorsal skin of BALB/c and
BALB/c-Uvs1 mice. (A) Mast
cells per mm2 dermal area. (B)
Mast cells per mm horizontal
field length in the dermis and
SCFT of BALB/c (–, n 5 9) and
BALB/c-Uvs1 ( Uvs1, n 5 11)
mice. (C) The area (mm2) of the
dermis per mm of fixed field
length for the same mice as
shown in B. Each point in A and
B represents the mean mast cell
number (expressed per area and
fixed field length, respectively),
and in C, area per fixed field length, for 30–60 measurements/mouse. In
A and C, the number of mice per group is shown in brackets.
Figure 5. The effect of (A) UVB and (B) histamine on the CHS re-
sponses of BALB/c and C57BL/6J mice to the hapten, TNCB. In A,
mice were UVB irradiated on their shaved dorsal surface with increasing
doses of UVB (290–320 nm) as indicated. In B, mice were injected sub-
cutaneously on their backs with increasing doses of histamine per mouse.
The mean change in ear swelling (1SD) for five mice/group is shown;
the groups of mice were always coded before challenge with hapten and
ear thickness measurements. *Result significantly different (P ,0.05) to
that of nonirradiated mice in A or control mice in B.
Figure 6. (A) Dermal mast cells
per mm2 area in dorsal skin of
W f/W f, heterozygous W f/1, and
wild-type 1/1 mice (n 5 three in
each group). Quantification was as
per Fig. 1 A. (B) The contact hy-
persensitivity response to TNCB
by W f/W f mice after exposure to
12 kJ/m2 UVB. The mean result
(1SD) for mice from three experi-
ments is shown. (C) The CHS re-
sponse to TNCB by W f/W f mice
after UVB irradiation or adminis-
tration of 200 and 2 mg histamine/
mouse. The mean result (1SD) for
five mice/group is shown. In B
and  C, a result significantly differ-
ent (*P ,0.05) to that of nonirra-
diated mice of the same type.2050 Mast Cells and Susceptibility to UVB Immunosuppression
Susceptibility of W f/W f Mice, Reconstituted in the Dorsal
Skin with Bone Marrow–derived Mast Cell Precursors, to Immu-
nomodulation by UVB Irradiation. Of the 18 W f/W f mice
administered bone marrow–derived mast cell precursors,
only one was judged to be poorly reconstituted after 8 wk
(6 wk 1 2 wk CHS assay; Fig. 7 A). In the reconstituted
mice, the mast cells were found nonuniformly distributed
in the dorsal skin and the data summarized in Fig. 7 A
comprise an average for 15 consecutive fields from the skin
of each mouse, some with numerous mast cells and others
with very few. There was no significant difference in the
dorsal mast cell numbers of reconstituted mice that had
been either UVB irradiated or nonirradiated 12 d before
skin sampling.
Susceptibility to UVB (12 kJ/m2) for systemic suppression
of CHS responses was evaluated in 13 mast cell–reconsti-
tuted W f/W f mice. The CHS response by all mice except
one was significantly suppressed by UVB irradiation; this
mouse was the one shown in Fig. 7 A to be poorly recon-
stituted and the results for this mouse have been excluded
from the results of Fig. 7 B.
Discussion
The evidence supporting the hypothesis that mast cells
determine susceptibility to UVB-induced systemic immu-
nosuppression is of two types. (a) In different strains of
mice, susceptibility to UVB immunosuppression correlated
with dermal mast cell prevalence and the prevalence in
W f/W f mice was insufficient to mediate susceptibility.
This established a correlation. (b) The ability of reconstitu-
tion of the dorsal skin of W f/W f mice with mast cells to
confer susceptibility to UVB-induced systemic immuno-
suppression confirmed the functional role of mast cells in
this response, and eliminated the concern that the lack of
responsiveness of unreconstituted W f/W f mice to UVB
might be the result of other abnormalities (anemia, albino
nature) of these mice. The results with the albino BALB/c-
Uvs1 mice also argued against the possibility that pigment
was contributing in this study to the extent of susceptibility
of mice to systemic immunomodulation by UVB. In a pre-
vious study, it was confirmed that Uvs1 was not genetically
linked to 12 chromosomal markers including the pigment
genes b (brown) and c (albino) (8).
By use of a combination of histamine types 1 and 2 re-
ceptor antagonists, we have previously shown that hista-
mine is an important regulatory molecule in the pathway(s)
by which UVB regulates systemic CHS responses in mice
(14). The source of the histamine had not been confirmed.
These studies implicate mast cell–derived histamine as an
important contributor to a pathway that determines degree
of susceptibility of mice to UVB-induced systemic, but not
local, suppression of CHS responses. The histamine con-
tent of dermal mast cells as estimated using quantitative
video image analysis did not vary significantly for different
mouse strains. However, there was greater than a twofold
increase in mast cell prevalence in the dermis of the
C57BL/6J mice, i.e., UV highly susceptible mice, than in
the dermis of the poorly susceptible BALB/c mice. In fact,
there was a direct correlation between dermal mast cell
prevalence and susceptibility to UVB-induced systemic
suppression of CHS responses. Dermal mast cells in the
BALB/c-Uvs1  mice were also increased to a level similar to
that of DBA/2 mice (Fig. 1 A). The level of mast cell prev-
alence is consistent with the previously reported extent of
suppression of CHS responses in BALB/c-Uvs1 mice with
4.5 kJ/m2 UVB (8). Overall, these objective measures of
histamine in stained sections suggest a correlation between
Table 1. Effect of UVB Irradiation on Immune Responses in Mast 
Cell–depleted Mice
UVB (12 kJ/m2)
Nonsensitized Sensitized
22 1
DTH responses to allogeneic spleen cells*
W f/1 0.01 6 0.02 0.13 6 0.01 0.02 6 0.02‡
W f/W f 0.01 6 0.01 0.10 6 0.01 0.08 6 0.01
CHS responses to TNCB applied for sensitization at the irradiated 
site (local CHS)§
W f/1 0.03 6 0.02 0.26 6 0.01 0.14 6 0.01‡
W f/W f 0.03 6 0.01 0.26 6 0.01 0.13 6 0.01‡
*Mean swelling (mm) of the hind footpad (6SD, n 5 4 mice, 8 foot-
pads) 24 h after challenge.
‡P ,0.05.
§Mean swelling (mm) of ears (6SD, n 5 5 mice, 10 ears) 24 h after
challenge.
Figure 7. Reconstitution of the dorsal skin of W f/W f mice with bone
marrow–derived mast cell precursors. (A) Mast cells per mm horizontal
field length in the dermis and SCFT of wild-type (1/1, n 5 7), W f/W f
(Wf; n 5 7), and W f/W f mice reconstituted with bone marrow–derived
mast cell precursors (BMWf; n 5 18). (B) The effect of UVB (12 kJ/m2)
on the systemic CHS response to the hapten, TNCB, by wild-type (1/1),
W f/W f, and W f/W f mice reconstituted with bone marrow–derived mast
cell precursors (BMW f/W f). The mean change in ear swelling (1SD) for
5 mice/group is shown with the exception of 12 UVB-irradiated BMW f/
W f mice; the groups of mice were coded before challenge with hapten
and ear thickness measurements. *A result significantly different (P ,0.05)
to that of nonirradiated mice.2051 Hart et al.
total histamine that may be released from dermal mast cells
after degranulation and the extent of systemic immuno-
modulation after UVB exposure.
That histamine was a component of a pathway defining
degree of susceptibility of mice to UVB-induced systemic
suppression of CHS responses was supported by further in
vivo experiments. C57BL/6J and BALB/c mice differed in
their susceptibilities to UVB for decreased CHS responses,
but were similar in their susceptibilities to histamine-induced
suppression of CHS responses. In addition, systemic CHS
responses by mast cell–depleted mice (W f/W f) were not
suppressed after UVB irradiation, but were susceptible to
suppression by histamine. If keratinocytes were producing
histamine after UV irradiation as recently reported in vitro
(20), it was not sufficient to suppress the CHS response in
W f/W f mice. We believe that we have administered phys-
iological concentrations of histamine to the mice; we esti-
mated that the dermis of 8 cm2 dorsal skin (z270 mm deep,
z40 mast cells/mm2 horizontal section of dermis, and 3–5
pg histamine/mast cell; reference 20) contains z8 mg hista-
mine. This must be considered a crude estimation of avail-
able histamine, as not all histamine would be released from
degranulating mast cells. Whether histamine was the only
important mediator from mast cells was not established. A
low, but significant, level of UVB-induced immunosup-
pression was still detected in the mice administered hista-
mine receptor antagonists (14). The potential contribution
of mast cell–derived TNF-a and IL-4 to UVB-associated
immunomodulation is currently under investigation. How-
ever, it may be that there was insufficient histamine recep-
tor antagonist available at histamine’s site(s) of action to en-
sure total inhibition.
UVB was also unable to suppress DTH responses in the
W f/W f mice and implicates mast cells and their products in
the regulation of this other systemic response. In contrast,
there was no evidence for mast cell involvement in the
modulation by UVB of CHS responses when the sensitiz-
ing hapten was applied to the irradiated site. These results
suggest that antigen-presenting cells at a distant, nonirradi-
ated site, but not at the irradiated site, are susceptible to im-
munomodulation, directly or indirectly, by mast cell prod-
ucts.
It is uncertain whether UV triggers dermal mast cell de-
granulation directly or indirectly. Signals from sensory
nerve fibres originating in the epidermis may be involved
(21).  Trans-urocanic acid (UCA) is a histidine-derived
product in the stratum corneum of the skin (22) and has
been implicated as a photoreceptor for UV-induced immu-
nosuppression (23). There has been a report that cis-UCA,
an immunosuppressive molecule and the product of UV-
induced isomerization of trans-UCA, can stimulate mast cell
degranulation (24). Mast cell degranulation induced by cis-
UCA would support observations by us assaying systemic
CHS responses (our unpublished data) and by others (25) of
differences in response to cis-UCA by BALB/c and C57BL/6J
mice, the latter being better responders to cis-UCA.
The mechanisms by which histamine alone, or together
with other mast cell or keratinocyte products, signals sys-
temic immunosuppression are not known. Histamine stim-
ulates prostaglandin E2 production by cultured human ker-
atinocytes (12, 13); prostaglandin E2 may act locally on
epidermal cells (26), in lymph nodes (27), or systemically
(28). Further, by indomethacin administration to mice,
prostanoids have been shown to be responsible for at least
50% of the systemic suppression of CHS responses by UVB
irradiation (13). There is also evidence that DNA is a UVB
photoreceptor that initiates immunosuppression (29, 30).
Damage to DNA can regulate the transcription in epider-
mal cells of regulatory cytokines (e.g., IL-10 [31], TNF-a
[7, 32]) and adhesion molecules that enable cell–cell inter-
action (e.g., intercellular adhesion molecule 1 [ICAM-1];
reference 33). However, whether there is a relationship be-
tween histamine and other mast cell products, and cyclobutyl
pyrimidine dimer formation in DNA of UVB-irradiated
cells (30), and the enzymes responsible for dimer repair, is
not known. With respect to UV-induced IL-10 produc-
tion, it has been reported that UVB can suppress systemic
CHS responses, but not DTH responses, in IL-10–deficient
mice (34) and suggests that IL-10 may not be an important
molecule in determining responses to UVB irradiation in Wf/
Wf mice. Histamine may directly influence the migration
of immune cells into the UV-irradiated site, or to nearby
lymph nodes, and regulate their proliferation and cytokine
profiles (35–38).
In conclusion, our results show that mast cells contribute
critically to the manifestation of UVB-induced systemic
suppression of CHS and DTH responses. Further, they add
to our previous suggestion that histamine is one important
component of the pathway to immunosuppression (14) and
indicates mast cells as the source of the histamine. Down-
regulation of systemic immune responses in mice after
UVB exposure correlated directly with the prevalence of
histamine-containing dermal mast cells. In addition, the
strains of mice investigated were equivalently susceptible to
the immunomodulatory effects of exogenous histamine,
further emphasizing the relationship of dermal mast cell
prevalence with susceptibility to UV systemic immuno-
modulation. The mechanism(s) by which histamine, and
potentially other mast cell products, can modulate immune
reactivity remains an unanswered question. The answers
will be very important in our quest to understand and pre-
vent or treat the harmful effects of UVB that are becoming
of greater concern due to greater ozone depletion in the
earth’s stratosphere.
We are grateful to Mr. J. Brennan and Ms. K. Clark for performing the Csaba’s mast cell stain, and to our
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